Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device .
Bardy Diagnostics has raised $10.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Bardy Diagnostics's investors include SV Health Investors, HealthQuest Capital, Lumira Ventures, Aphelion Capital, Health Enterprise Partners.
Bardy Diagnostics is headquartered in Seattle, United States.
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device .
Bardy Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bardy Diagnostics — Funding & Investors." VCBacked, May 8, 2025, https://www.vcbacked.co/company/bardy-diagnostics. Accessed November 11, 2026.
VCBacked. (2025). Bardy Diagnostics — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/bardy-diagnostics
{{cite web |title=Bardy Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/bardy-diagnostics |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Bardy Diagnostics? Request a listing update